The presentation, pattern of acute illness, and incidence of learning difficulties are described in 63 (33 boys, 30 girls) children with salt wasting 21-hydroxylase deficiency, drawn from a cohort study of congenital adrenal hyperplasia in the South West Region of England between 1968 and 1988. Thirty boys presented with a salt losing crisis from birth whereas the other three boys presented between 2 and 14 months of age with failure to thrive and hyponatraemia. Diagnostic uncertainty led to 13 (43%) of 30 girls developing a salt losing crisis. Five girls were misassigned as boys at birth. There were four deaths in the group, two due to salt losing crisis, one to complications of prematurity possibly compounded by 21-hydroxylase deficiency, and one from heart failure probably related to an excess of steroids. Acute admissions were common, especially during the first year of life, with convulsions in 7% of admissions. The 9% incidence of hypoglycaemia was considered to be an underestimate as blood glucose was measured in only 56 (22%) of 254 admissions. No convulsions occurred in the 38 (15%) admissions where the parents had given intramuscular hydrocortisone before bringing the child to hospital. A high incidence of learning difficulties was found among the 59 surviving children (9/30 (30%) boys and 6/29 (21%) girls), and in only two children could any factor other than 21-hydroxylase deficiency be invoked. Analysis of the subgroup with learning difficulties indicated that they were more ill at presentation with a significantly higher incidence of hypoglycaemia, and that growth in the first year was significantly worse.
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It is concluded that congenital adrenal hyperplasia remains a formidable disorder with an appreciable mortality and morbidity. The crisis in three. The median age of salt losing crisis in all 13 girls was 12 days (range 9-33). Thirty (91%) of the 33 boys presented with a salt losing crisis before 6 weeks of age with a median age at hospital admission of 12 days (range 5-42). The remaining three boys presented later at 2, 1 1, and 14 months of age with failure to thrive, hyponatraemia, and constipation. These infants were presumed to have a milder 2 1-hydroxylase defect.
The common symptoms in the 56 children (23 girls and 33 boys) showing biochemical evidence of salt loss included vomiting (29 (52%)), poor feeding (30 (54%)), and poor weight gain or weight loss (42 (75%)). Pigmentation of the labia or scrotum was recorded in 23 (41%) patients, but often in retrospect only. Mean plasma sodium was 120-5 mmol/l (range (SD) 100-140 (9)) and plasma potassium 7 9 mmolI (range (SD) 5-7-13-3 (1.2)). Blood glucose (available in only 20 patients) was 3-2 mmol/l (range (SD) 0-5-6-6 (1-8)), nine (16%) infants showing frank hypoglycaemia (05-2 0 mmol/l).
There were three early and one late infant deaths. Two boys died, in 1968 and 1975, from salt losing crisis. Another boy born at 33 weeks' gestation in 1984 deteriorated on day 5 while receiving care for suspected necrotising enterocolitis and respiratory distress syndrome, but the diagnosis of congenital adrenal hyperplasia was not made until 21 days. He was subsequently found to have spastic quadriplegia and died aged 7 months. The fourth death was a girl who presented at 34 weeks' gestation with ambiguous genitalia and a diagnostic increase in plasma 1 7-hydroxyprogesterone. She developed respiratory distress syndrome and died on day 9 from heart failure after receiving large doses of glucocorticoids, daily doses ranging between 400 and 1500 mg/m2 of hydrocortisone or equivalent. A necropsy showed no evidence of congenital heart disease and her heart failure was assumed to be mainly related to the use of steroids.
ACUTE ILLNESS
An attempt was made to separate acute illness into two categories: acute adrenal insufficiency related either to undertreatment, intercurrent illness, or both; and illness related to glucocorticoid, mineralocorticoid, or fluid excess.
Thirty two (54%) of the 59 surviving children were admitted as emergencies during the first year of life with a total of 90 admissions. After the first year there were 164 admissions of 40 children. Only six (11%) of the 57 children who were over 1 year of age by the end of the study period had not been admitted to hospital at some stage. Common symptoms included fever, vomiting, poor feeding, and diarrhoea. Fludrocortisone had been inappropriately reduced or stopped one month previously in three children and hydrocortisone or cortisone acetate had been reduced in two children, usually because the diagnosis of 21-hydroxylase deficiency was in doubt.
Hypoglycaemia (blood glucose less than 2-5 mmoIl) was documented in 24 (9%) (7%) . Approximately 10% of children had hypoglycaemia on admission, but as blood glucose was measured in barely a quarter the true incidence was presumably much higher. To prevent acute adrenal decompensation we constantly reiterate to the families the need to increase the dose of glucocorticoid in all but the mildest intercurrent illness. The higher dose of hydrocortisone is doubled and given three times each day. We also teach families to inject 50 or 100 mg hydrocortisone phosphate intramuscularly whenever the child is particularly unwell or has vomiting and diarrhoea, and it is of note that no convulsions occurred in the 38 admissions in whom this procedure was followed.
The most striking finding in this study is the high incidence of learning difficulties. Only crude measures of intellectual impairment such as the need for special educational help could be used in such a retrospective study and it is likely that with more sophisticated analysis the yield would have been even higher. Although unrelated disorders could account for learning difficulties in two of the children, there was no reason to suspect a cause other than complications of congenital adrenal hyperplasia in the remainder. We therefore conclude that the relation between learning difficulties and salt wasting 21-hydroxylase deficiency is genuine, but we have been unable to find comparable reports, though subsequent experience in the west of Scotland has been similar (Donaldson, personal observation). Thilen and Larsson found only two instances of neurological handicap in a series of 150 patients between 1969 and 1986,3 whereas earlier studies have indicated an increased IQ in subjects with the disorder, though boys with salt wasting disease were underrepresented in the population studied.'2 Nass and Baker have shown that children with salt wasting disease have a lower IQ (104 v 117) than simple virilisers,'3 but the severity of intellectual impairment in our study seems much greater. This may reflect the advantages of studying a cohort taken from a geographically defined area, rather than patients from one or more hospitals.
The learning impairment seen in this study may have been due to a variety of factors occurring in the early years. These could include metabolic derangement from the initial salt losing crisis, adrenal decompensation from acute illness, and over treatment with glucocorticoid and mineralocorticoid. Comparison between children with and without learning difficulties showed that the impaired group tended to be more symptomatic at presentation, with significantly lower initial blood glucose values, more common acute admissions after infancy, a higher incidence of hypoglycaemic convulsions, and poorer growth during the first year. The salt losing crisis was the only significant adverse event in the two most handicapped children in this study. We believe that the intellectual outcome in 21-hydroxylase deficiency should be studied prospectively, and that the contribution of the salt losing crisis should be examined by carrying out neonatal screening in one or more large regions of the United Kingdom, comparing the children with matched controls and with affected subjects from other regions not practising screening. The findings of such a study might add weight to the argument for the institution of a national screening programme which would also serve to limit the physical and psychological handicap of the simple virilising variety of this disorder.
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